Our groundbreaking Plasma-based Bioactive Materials (PBM) are designed to improve
patient outcomes and thereby potentially reduce healthcare costs across a variety of clinical settings
Our dedicated team has a passion for making a difference in the lives of patients. We are developing multiple transformational PBM products to address unmet clinical needs.
Our patented Plasma-based Bioactive Materials (PBMs) promote healing.
Our PBMs contain a wide array of growth factors found in platelet-enriched plasma from allogeneic sources.
A First-In-Human (FIH) clinical trial was successfully completed on the use of the Bone Healing Accelerant to treat open tibia fractures (trauma).
Technology
Clinical Data
Accelerate Healing When It Is Needed the Most
Our proprietary process binds and crosslinks lyophilized plasma and platelet-derived proteins to extend the presence of our bioactive materials when implanted. In vivo, our PBMs break down over time via proteolysis, releasing the active biologics to accelerate healing.
Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity
PITTSBURGH & FLAGSTAFF, Ariz.--(BUSINESS WIRE)--Carmell Corporation (Nasdaq: CTCX) (“Carmell”), a regenerative care company today announced the successful closing of the previously announced merger with Flagstaff-based Axolotl Biologix, a profitable regenerative medicine company developing products for active soft tissue repair, aesthetics and orthopedic indications (“Axolotl”).Read more
Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
PITTSBURGH & FLAGSTAFF, Ariz.--(BUSINESS WIRE)--Carmell Therapeutics Corporation (Nasdaq: CTCX) (“Carmell”), a regenerative medicine company today announced the execution of a definitive agreement and plan of merger (the “Merger Agreement”) with Flagstaff-based Axolotl Biologix, a profitable regenerative medicine company developing products for active soft tissue repair, aesthetics and orthopedic indications (“Axolotl”).Read more
See Open Positions